相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of a prognostic 5-Gene expression signature for gastric cancer
Jun-Yi Hou et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
May High MMP-2 and TIMP-2 Expressions Increase or Decrease the Aggressivity of Oral Cancer?
Bijayatha Shrestha et al.
PATHOLOGY & ONCOLOGY RESEARCH (2017)
Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma
Timothy A. Dinh et al.
SCIENTIFIC REPORTS (2017)
Host immune response index in gastric cancer identified by comprehensive analyses of tumor immunity
Charny Park et al.
ONCOIMMUNOLOGY (2017)
Notch1 pathway-mediated microRNA-151-5p promotes gastric cancer progression
Kai-Wen Hsu et al.
ONCOTARGET (2016)
miR-4443 Participates in the Malignancy of Breast Cancer
Xiu Chen et al.
PLOS ONE (2016)
TIMP-2 gene methylation in cervical precursor and invasive lesions
Yara Furtado et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2015)
Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-2: Prognostic biological markers in invasive prolactinomas
Guliz Demirelli Gultekin et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2015)
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
Razvan Cristescu et al.
NATURE MEDICINE (2015)
Prognostic Value of Tissue Inhibitor of Metalloproteinase-2 Expression in Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
Lin Zhu et al.
PLOS ONE (2015)
Serum levels and tissue expression of matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinases 2 (TIMP-2) in colorectal cancer patients
Magdalena Groblewska et al.
TUMOR BIOLOGY (2014)
Role of Matrix Metalloproteinase (MMP) 2 and MMP-9 in Soft Tissue Sarcoma
Hyun Kee Yang et al.
CLINICS IN ORTHOPEDIC SURGERY (2014)
Matrix metalloproteinase 2 (MMP-2) and their tissue inhibitor 2 (TIMP-2) in gastric cancer patients
M. Lukaszewicz-Zajac et al.
ADVANCES IN MEDICAL SCIENCES (2013)
Role of serum concentration of VEGFR1 and TIMP2 on clinical outcome in primary cervical cancer: Results of a companion protocol of the randomized, NOGGO-AGO phase III adjuvant trial of simultaneous cisplatin-based radiochemotherapy vs. carboplatin and paclitaxel containing sequential radiotherapy
E. I. Braicu et al.
CYTOKINE (2013)
Expression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survival
Ferhat Ozden et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Expression of matrix metalloproteinase-2 and its tissue inhibitor-2 in fetal and neoplastic thyroid tissue and their significance as diagnostic and prognostic markers in papillary carcinoma
Ilona Marecko et al.
CANCER BIOMARKERS (2012)
Enhanced Immunoreactivity of TIMP-2 in the Stromal Compartment of Tumor as a Marker of Favorable Prognosis in Ovarian Cancer Patients
Agnieszka Halon et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2012)
Immunoreactivity for TIMP-2 is associated with a favorable prognosis in endometrial carcinoma
Maria Honkavuori-Toivola et al.
TUMOR BIOLOGY (2012)
Molecular Classification of Gastric Cancer: A New Paradigm
Manish A. Shah et al.
CLINICAL CANCER RESEARCH (2011)
Clinical significance of serum levels of matrix metalloproteinase 2 (MMP-2) and its tissue inhibitor (TIMP-2) in gastric cancer
Barbara Mroczko et al.
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA (2011)
Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer
Kyung Sook Park et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: A survival study
Andreia Santos et al.
VETERINARY JOURNAL (2011)
Increased matrix metalloproteinases 2 and 9 and tissue inhibitor of matrix metalloproteinase 2 expression is associated with progression from vulvar intraepithelial neoplasia to invasive carcinoma
Milla Maatta et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2010)
7th Edition of the AJCC Cancer Staging Manual: Stomach
Kay Washington
ANNALS OF SURGICAL ONCOLOGY (2010)
Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancy
Alex Y. Strongin
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells
Chunling Wang et al.
LEUKEMIA RESEARCH (2010)
Clinical Impact of MMP and TIMP Gene Polymorphisms in Gastric Cancer
Hakan Alakus et al.
WORLD JOURNAL OF SURGERY (2010)
Low Circulating Levels of ProMMP-2 Are Associated with Adverse Prognosis in Bladder Cancer
Kaija Vasala et al.
TUMOR BIOLOGY (2008)
Key Issues in Conducting a Meta-Analysis of Gene Expression Microarray Datasets
Adaikalavan Ramasamy et al.
PLOS MEDICINE (2008)
Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism
Silvia D'Alessio et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma
Nozomu Kawata et al.
UROLOGY (2007)
Immunoexpression and prognostic significance of TIMP-1 and-2 in oral squamous cell carcinoma
JC de Vicente et al.
ORAL ONCOLOGY (2005)
Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis
A Katayama et al.
CLINICAL CANCER RESEARCH (2004)
The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma
B Davidson et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2002)
Expression of tissue inhibitors of metalloproteinases (TIMPs) in gastric cancer
YE Joo et al.
DIGESTIVE DISEASES AND SCIENCES (2000)
分享论文
